OBJECTIVE: The purpose of this study was to develop a cystic fibrosis (CF)-specific patient and family experience of care survey that CF care centers could use to inform quality improvement efforts. METHODS: A literature search and query of CF care centers was conducted to identify existing surveys. Individuals with CF, their families, and health care professionals were also asked what to include. Following this process, a draft survey was developed and then reviewed by focus groups. Finally, a version was piloted at 25 CF care centers to validate and further refine the instrument. RESULTS: No CF-specific surveys were found in the literature. Focus group participants stated that they understood the survey questions and that they covered important aspects of care, particularly infection control. The pilot test of the instrument with 485 participants supported its validity by demonstrating significant differences across centers and that most of the 3 care dimensions had acceptable internal consistency (Cronbach α: adults, 0.71-0.85; children, 0.68-0.79). CONCLUSION: A CF-specific patient and family experience of care survey was developed with input from individuals with CF, their families, and health care professionals. The instrument was validated and has been deployed to CF care centers.
OBJECTIVE: The purpose of this study was to develop a cystic fibrosis (CF)-specific patient and family experience of care survey that CF care centers could use to inform quality improvement efforts. METHODS: A literature search and query of CF care centers was conducted to identify existing surveys. Individuals with CF, their families, and health care professionals were also asked what to include. Following this process, a draft survey was developed and then reviewed by focus groups. Finally, a version was piloted at 25 CF care centers to validate and further refine the instrument. RESULTS: No CF-specific surveys were found in the literature. Focus group participants stated that they understood the survey questions and that they covered important aspects of care, particularly infection control. The pilot test of the instrument with 485 participants supported its validity by demonstrating significant differences across centers and that most of the 3 care dimensions had acceptable internal consistency (Cronbach α: adults, 0.71-0.85; children, 0.68-0.79). CONCLUSION: A CF-specific patient and family experience of care survey was developed with input from individuals with CF, their families, and health care professionals. The instrument was validated and has been deployed to CF care centers.
Authors: D Pougheon Bertrand; A Fanchini; P Lombrail; G Rault; A Chansard; N Le Breton; C Frenod; F Milon; C Heymes-Royer; D Segretain; M Silber; S Therouanne; J Haesebaert; C Llerena; P Michel; Q Reynaud Journal: Orphanet J Rare Dis Date: 2022-02-22 Impact factor: 4.123
Authors: Daisy Goodman; Greg Ogrinc; Louise Davies; G Ross Baker; Jane Barnsteiner; Tina C Foster; Kari Gali; Joanne Hilden; Leora Horwitz; Heather C Kaplan; Jerome Leis; John C Matulis; Susan Michie; Rebecca Miltner; Julia Neily; William A Nelson; Matthew Niedner; Brant Oliver; Lori Rutman; Richard Thomson; Johan Thor Journal: BMJ Qual Saf Date: 2016-04-13 Impact factor: 7.035